To address these questions, we have established a variety of different in vitro and in
vivo cell systems that allow us to dissect molecular mechanisms and function.
Not exact matches
This in
vivo reconstitution
system provides a new approach for examining ligand binding and G protein coupling to
cell surface receptors.
A microscope image shows many of the immune
system's dendritic
cells that were collected from a 3 - D scaffold three days after in
vivo injection.
«With Teresa Woodruff's research using Draper's human organ
system platform, we have a compelling demonstration of the importance of a microenvironment that permits
cells to function in vitro as they would in
vivo, and the power of being able to interconnect organ models on a platform and operate them in a stable and precise manner for weeks to months,» said Jeffrey T. Borenstein, a biomedical engineer at Draper.
After testing the
system both in vitro and in
vivo in an animal model, Scott's team demonstrated they could administer a subcutaneous injection that slowly delivered nanomaterials to
cells in lymph nodes for over a month in a controlled fashion.
«An important, overarching goal of the field is to develop culture
systems using primary
cells with minimal ex
vivo [external] manipulation.
While humanized mouse models provided a logical first approach to examine in
vivo efficacy of CXCR4 disruption, this
system does not make it possible to fully assess the functional impact of CXCR4 loss on CD4 + T
cell function.
In this project, we aim to analyze the physiological and developmental functions of two metalloproteases acting at distinct surface regions of heart and muscle
cells in the genetically accessible in
vivo model
system Drosophila.
Hypothesis driven approaches to vaccinology can utilise the knowledge gained from mechanistic mouse models and our molecular understanding of intrinsic defects to human
cells.5 However, caution is required when extrapolating data from murine models, as there are substantial differences between immune ageing in mice and humans.6 Nevertheless, model
systems and ex
vivo analyses of molecular alterations in aged human
cells have identified multiple changes in the vaccination response with age and the aged immune
system in general.
MimEX ™ Tissue Models
System provides a platform for the isolation, expansion, and differentiation of adult epithelial stem
cells into 3 - D ex
vivo organ tissue.
This video provides an overview of MimEX ™ Tissue Model
Systems, a next - generation 3 - dimensional (3 - D)
cell culture platform for the generation of ex
vivo epithelial - derived organ tissue.
Using Cultrex ® BME, MimEX ™ Tissue Models
System provides a platform for the isolation, expansion, and differentiation of adult epithelial stem
cells into 3 - D ex
vivo organ tissue.
With this information, they turned to a
cell culture
system to see if any Cpf1 nucleases would exhibit in
vivo activity in mammalian
cells.
For this purpose, we have generated transgenic lines that monitor in
vivo and in real - time the proliferation of β -
cells using the FUCCI (Fluorescent Ubiquitination - based
Cell Cycle Indicator)
system.
We will mine and exploit information from studies and screens in model organisms, but our primary focus is on the paradigmatic mammalian stem
cell systems - haematopoiesis and epithelia in
vivo, and embryonic and neural stem
cells in vitro.
Expression profiling of fungi and the mammalian host during in
vivo infections and ex
vivo infections of culture immune
system cells
ViaCyte is engineering the Encaptra ®
cell delivery
system to enable implanted PEC - 01 ™
cells to survive and thrive in
vivo and to differentiate into functional insulin - producing
cells.
Topics covered include embryonic stem
cells, pluripotency, germline stem
cells, tissue - specific stem
cells, stem
cell differentiation, epigenetics, stem
cell genomics and
systems biology, genome reprogramming, cancer stem
cells, stem
cell niches, stem -
cell - based disease models, nuclear transfer technology, bioengineering, drug discovery, in
vivo imaging of stem
cells, therapeutic applications, regenerative medicine, clinical and translational insights, stem
cell research policies, ethical issues, and technical or resource - based innovations.
We work exclusively in the human
system, mostly with primary
cells and tissue, with a constant concern of recreating conditions that mimic the in situ and in
vivo settings.
ZVex ® and GLAAS ™ are our complementary discovery platforms designed to activate and expand the immune
system's natural ability to create tumor - specific cytotoxic T
cells (CTLs) in
vivo.
From numerous studies in the Xenopus paired oocyte
system and various
cell culture
systems, a reasonable assumption might be that if two
cells express the same connexin or innexin and lie in close membrane apposition, gap junctions will probably be established between them; this assumption has not been investigated rigorously in
vivo.
Our goal is to create a microfluidic 3D
cell culture
system representing a «placenta - on - a-chip» in order to mimic the nutrient / waste transfer between maternal blood and fetal blood that occurs in the cotyledon section of the placenta, and to test and observe the effects of ethanol within the maternal bloodstream and compare it to a similar in
vivo situation.
«Both [the] in
vivo and in vitro experiments have shown striking anticancer effects... demonstrated that phytate is a broad - spectrum antineoplastic agent,» meaning antitumor agent across different
cells and tissue
systems.